Cetylic acids, when administered to ethanol‐treated rats and 3T3‐L1 adipocytes, increase adiponectin secretion and enhance the activity of the mouse adiponectin promoter, thus exerting a protective influence against alcoholic fatty liver disease (You et al., 2005). This evidence concerns the gene ADIPOQ and alcoholic fatty liver disease.